Clinical Drug Investigation

Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer
pp. 161-168(8)
Authors: Schuette W.; Bork I.; Wollschläger B.; Schädlich S.

Gabapentin and the Prophylaxis of Bipolar Disorders in Patients Intolerant to Lithium
pp. 169-174(6)
Authors: Mauri M.C.; Laini V.; Scalvini M.E.; Omboni A.; Ferrari V.M.S.; Clemente A.; Salvi V.; Cerveri G.

Efficacy of Concentrated n-3 Fatty Acids in Hypertriglyceridaemia: A Comparison with Gemfibrozil
pp. 175-181(7)
Authors: van Dam M.; Stalenhoef A.F.H.; Wittekoek J.; Trip M.D.; Prins M.H.; Kastelein J.J.P.

Efficacy and Tolerability of the Anti-inflammatory Throat Lozenge Flurbiprofen 8.75mg in the Treatment of Sore Throat: A Randomised, Double-Blind, Placebo-Controlled Study
pp. 183-193(11)
Authors: Benrimoj S.I.; Langford J.H.; Christian J.; Charlesworth A.; Steans A.

Effect of Variable Inspiratory Flow Rate on the Performance of the Budesonide Rhinocort Turbuhaler
pp. 195-201(7)
Authors: devalia J.L.; Prime D.; Richards D.H.

Relative Bioavailability of Two Enteric-Coated Formulations of Omeprazole following Repeated Doses in Healthy Volunteers
pp. 203-210(8)
Authors: Vaz-da-Silva M.; Hainzl D.; Almeida L.; Dolgner A.; Silveira P.; Maia J.; Soares-da-Silva P.

Human Bioequivalence Study of Clarithromycin from Two Tablet Formulations after Single Oral Administration
pp. 211-217(7)
Authors: Niopas I.; Daftsios A.C.; Nikolaidis N.

Plasma Pharmacokinetics and Tissue Penetration of Alatrofloxacin in Morbidly Obese Individuals
pp. 219-224(6)
Authors: Pai M.P.; Iv J.B.; Amsden G.W.

Digoxin Toxicity: Evaluation in Clinical Practice with Pharmacokinetic Correlations
pp. 225-232(8)
Authors: Lecointre K.; Pisanté L.; Fauvelle F.; Mazouz S.

Possible Digoxin-Azithromycin Interaction in a Child
pp. 233-234(2)
Author: Miner P.J.

Possible Digoxin-Azithromycin Interaction in a Child
pp. 233-234(2)
Authors: Ten Eick A.P.; Reed M.D.